PharmAccess mobilizes public and private resources for the benefit of doctors and patients through clinical standards and quality improvements, loans for healthcare providers, health insurance, mHealth innovations and operational research.
Our Team
Supervisory Board
Supervisory Board
The Supervisory Board of Stichting PharmAccess Group Foundation supervises the Executive Board of Stichting PharmAccess Group Foundation in its role of Statutory Board for all underlying foundations, including Stichting PharmAccess International.
The members of the Supervisory Board are:
Prof. Khama Rogo – Chair of Supervisor Board
Prof. Khama Rogo has been Lead Health Sector Specialist at the World Bank, and Head of the World Bank Group’s Health Africa Initiative. Prof. Rogo, a highly respected specialist in Reproductive Health and Cancer, chairs Kenya’s National Tobacco Control Board and is a prominent advocate, activist, and global authority on women’s health. He is a Professor in Obstetrics and Gynecology, and a prominent advocate and global authority on reproductive health issues. He is also the author of over 100 papers and book chapters and continues to inspire a large audience on the future of healthcare in sub-Saharan Africa. Prof. Rogo resides Sagam, West Kenya.
Kees Verbeek – Supervisory Board Member
Kees Verbeek has over 40 years of experience in commercial banking, credit, risk, and governance with a strong focus on emerging markets. Before joining Rabobank in 1998, he worked in Africa in both development aid as well as commercial roles, and ended his time at Rabobank as Chief Representative Officer in charge of their Kenyan operation. As an authorized side function, Verbeek served as a member of the Investment Committee of Veris Investments, an impact-oriented private equity firm focused on food security in Africa, among others. In 2021, he retired from Rabobank. Verbeek currently holds several board and investment committee positions all related to Africa.
Els Boerhof – Vice Chair and member of the Supervisory Board
Els Boerhof is currently the Managing Partner and co-owner at the impact investment firm Goodwell Investment, providing risk capital and hands-on support to fast-growing businesses in emerging markets. In 2021 she was named one of the 50 women leading the sustainability in finance movement in The Netherlands by Dutch Magazine P+. She has a broad experience in investment and banking in emerging markets. Ms. Boerhof is a member of the Supervisory Board of Musoni System and was a member of the board of the Directors of the CreditAccess Asia N.V. and Women’s World Banking Ghana. She holds a master degree in Economics from the Tilburg University.
Margriet Schneider – Supervisory Board Member
Margriet Schneider is a physician and healthcare executive with over three decades of experience in clinical medicine, research, and leadership. As an internist and infectious disease specialist, she was part of the early team of the Department of Immunology and Infectious Diseases at UMC Utrecht, focusing on HIV/AIDS care during a period of landmark breakthroughs in research and patient-centered care. She served as program director for internist training and held leadership roles in quality, safety, and divisional management at UMC Utrecht. From 2015 to 2024, she served as CEO of UMC Utrecht, one of the Netherlands’ leading academic medical centers.
Eelko Bronkhorst – Supervisory Board Member
Eelko Bronkhorst is the founder of Crosspath International, a boutique advisory and impact investing firm specializing in MSME banking, agrifinance, and fintech. From 2018 to 2025, he served as Chair of the Board of Directors at Advans Group, a leading microfinance and small business banking group across Asia and Africa. Previously, he spent 20 years with ABN Amro Bank and Rabobank in senior roles across the US, Asia, and Europe. Having grown up in Ethiopia and Tanzania, he brings a lifelong personal connection to Africa.